(Q54307148)

27 May 2018

title

Conserved cytostatic activity of aclarubicin in a doxorubicin selected friend leukaemia cell line with multifactorial multidrug resistance (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90287-N

5 December 2022

main subject

multiple drug resistance

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90287-N

5 December 2022

author name string

R. Erttmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832898

5 December 2022

M. Münchmeyer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832898

5 December 2022

G. Looft

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832898

5 December 2022

K. Winkler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832898

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832898

5 December 2022

publication date

1 January 1991

1 reference

27 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:027753799190287N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90287-N

https://api.elsevier.com/content/article/PII:027753799190287N?httpAccept=text/plain

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90287-N

European Journal of Cancer

5 December 2022

published in

1 reference

27 May 2018

volume

27

1 reference

27 May 2018

page(s)

1064

1 reference

27 May 2018

issue

8

1 reference

27 May 2018

9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90287-N

Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias

5 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90287-N

5 December 2022

Identifiers

1 reference

27 May 2018

1 reference

27 May 2018